FEATURED CONTENT

• Patient Caregiver Network Improves Post-Seizure Trial Data

  Discover how a pharmaceutical CRO addressed concerns about seizure diary timing in a rare disease study, leveraging insights from Medable's Patient Community Network to optimize data collection.

• Quality By Design: Better Data Using Participant Insights

  While clinical trials will always encounter challenges in driving quality experiences and data, there exists one approach that’s backed by regulatory agencies and proven to lead to better outcomes.

• Key Insights From The FDA's DHT Guidance

  Check out a summary of the FDA’s guidance Framework for the Use of DHTs in Clinical Trials and what it means for sponsors and investigators using these innovative tools.

• Taking eCOA Technology Deployment Off The Critical Path

  Consider this expedited review approach to facilitate the efficient evaluation of COAs and eCOAs, streamlining the pathway for successful trial execution.

• Digital Advancements In Clinical Development - What’s Next?

  Review this year's predictions for improving digital biomarkers and data analytics, bettering endpoint sensitivity and specificity, and reducing timelines and costs of clinical development.

• Patient Perspectives: The Balancing Act of Trial Participation

  While technology plays a vital role in clinical trials, learn why it shouldn't overshadow the need for empathy, patient-centered care, and recognition of the individual behind the data.

• ePROs: How They’re Transforming Oncology Research

  ePRO and eCOA are helping to overcome oncology-specific challenges in clinical research. Find out how you can make life easier for patients when it matters most.

• A Definitive Guide To Evidence Generation

  Obtain a complete understanding of enrollment, screening, consent, and data collection by diving into this introductory handbook on decentralized clinical trials.

• Unlocking Scalability In Pharma With AI

  Uncover how artificial intelligence and machine learning could emerge as the most pivotal technologies of our era, with the potential to facilitate scalability in pharmaceuticals and other industries.

• eCOA And Digital Platforms Reduce Diabetes Study Startup To 8 Weeks

  See how digital solutions came together to enable faster study startup by 50% for this top pharma company conducting a Phase 3 diabetes study within the weight loss market.

• Digital/Hybrid Trials Deliver Greater ROI Than Traditional Trials

  In this paper, Tufts CSDD outlines why and how modernized clinical trials can drive greater savings (up to $40,000,000 per study) than traditional trials.

• You Don’t Have To Digitize Everything, You Just Have To Start

  Feeling left behind by the sudden digitization of clinical trials? Decentralized clinical trials can be adapted to best serve the patient population, condition, or therapy you’re investigating.

• What Keeps Patients From Enrolling In Clinical Trials?

  Explore five key reasons patients may opt not to participate in clinical trials and learn how technology can help overcome patients’ concerns. 

• Using Electronic COAs/PROs To Capture The Patient Experience

  As telehealth solutions and mobile health devices help empower decentralized clinical trials, discover how study sponsors look for ways to further improve the patient and site experience while delivering high-quality data.

• How Medable Increased Oncology Safety Monitoring By 90x

  Oncology trials placed a heavy burden on patients due to travel burden, poor patient experience and multi-year clinical trial commitments. Sites also struggle with cancer trials due to enrollment delays, complex data workflows, and multiple amendments requiring re-consents. Today, there is a more effective, patient-first solution.

• How eConsent Primes Patients And Studies For Success

  Understand how the informed consent process ensures trial participants are adequately educated about the trial and what's required of them during the process while confirming their willingness to enroll.

• How And Why To Include Patients In The Design Of Clinical Trials

  In this Q&A, learn from Rosamund Round, Vice President, Patient Innovation Center and Decentralized Trials at Parexel, on how to include patients in the design of clinical trials for the benefit of all stakeholders.

• Are Sites On Board With The Shift To Decentralized Clinical Trials (DCTs)?

  As the Senior Director and Co-Owner of Coastal Carolina Research Center, Nathan Morton provides strategic planning and operational oversight for a dedicated research center and clinical staff of 50.

• Recommendations For Optimizing Televisits

  Discover the pros and cons of telehealth visits and what can be done to continuously improve them.

• Clinician Reported Outcomes: Let's Make It A Universal Language

  Discover the important role of clinician reported outcomes (ClinROs) when it comes to regulatory submissions.